Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul-Aug;14(4):665-669.
doi: 10.1016/j.dsx.2020.05.023. Epub 2020 May 12.

Convalescent plasma: A possible treatment protocol for COVID- 19 patients suffering from diabetes or underlying liver diseases

Ashish Yashwantrao Pawar  1 , Apoorva Prashant Hiray  2 , Deepak Devidas Sonawane  3 , Rajendra Sudhakar Bhambar  4 , Deelip Vishram Derle  5 , Yogesh Suresh Ahire  6
Affiliations
Review

Convalescent plasma: A possible treatment protocol for COVID- 19 patients suffering from diabetes or underlying liver diseases

Ashish Yashwantrao Pawar et al. Diabetes Metab Syndr. 2020 Jul-Aug.

Abstract

Background & aim: As on date, no specific treatment is available for devastating COVID-19 (SARS-CoV-2) infection. This pandemic viral infection has affected over 200 countries within a very short time and created a calamitous situation across the globe. As per WHO guidelines, the treatment is mainly symptomatic and supportive. This clinical protocol has not proven sufficient to save the lives of COVID-19 patients suffering from diabetes or having underlying liver diseases; hence there is utmost need to tackle this situation by other means such as Convalescent Plasma (CP) therapy.

Methods: A comprehensive literature survey was carriedout using Elsevier, PubMed, Taylor & Francis, Springer, Nature and Google search engines.

Results: The patients suffering from diabetes or liver dysfunction or any other underlying diseases are at greatest risk of SARS-CoV-2 infection. From the study, it is proved that plasma collected from the recovered patients of viral infection has considerable potential to treat the viral disease without the occurrence of adverse effects.

Conclusion: The CP therapy can be a possible life saving alternative to treat critical COVID-19 patients having diabetes or underlying liver dysfunction. Hence, randomised clinical trials are recommended at the earliest to save the lives of infected individuals of COVID-19.

Keywords: ACE2; COVID-19; Convalescent plasma; Diabetes; Liver diseases; Neutralizing Antibodies; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that they have no competing interests.

Figures

Image 1
Graphical abstract
Fig. 1
Fig. 1
Schematic mechanism of neutralizing antibodies. Neutralizing antibodies binds with Receptor bonding domain (RBD) of the SARS-CoV-2 Spike protein and inhibits the binding of RBD to ACE2 receptor as shown in the figure. The protruding portion (blue colour) highlights the antibody epitope.
Fig. 2
Fig. 2
Schematic representation of Passive antibody therapy for COVID -19 patients highlighting the major steps.
See this image and copyright information in PMC

References

    1. Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Feb 3 doi: 10.1038/s41586-020-2012-7. [Epub ahead of print] - DOI - PMC - PubMed
    1. https://www.worldometers.info/coronavirus/?
    1. International Diabetes Federation IDF diabetes atlas. 2019. https://www.diabetesatlas.org/en/ 9th edn. Brussels, Belgium.
    1. Ruan Q., Yang K., Wang W., Jiang L., Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020 Mar 3 doi: 10.1007/s00134-020-05991-x. - DOI - PMC - PubMed
    1. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. J Am Med Assoc. 2020 Feb 24 doi: 10.1001/jama.2020.2648. - DOI - PubMed

MeSH terms